Harvest Volatility Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,461
Closed -$1.27M 24
2023
Q2
$1.27M Sell
4,461
-731
-14% -$218K 0.25% 74
2023
Q1
$1.43M Sell
5,192
-887
-15% -$245K 0.29% 72
2022
Q4
$1.68M Sell
6,079
-1,618
-21% -$457K 0.34% 65
2022
Q3
$2.03M Sell
7,697
-319
-4% -$67.7K 0.35% 60
2022
Q2
$1.64M Sell
8,016
-939
-10% -$192K 0.26% 77
2022
Q1
$1.89M Buy
8,955
+8,946
+99,400% +$1.95M 0.21% 91
2021
Q4
$2.15K Sell
9
-6,859
-100% -$1.76M ﹤0.01% 102
2021
Q3
$1.94M Buy
6,868
+2,552
+59% +$836K 0.09% 73
2021
Q2
$1.5M Buy
4,316
+1,013
+31% +$307K 0.12% 61
2021
Q1
$924K Buy
3,303
+1,242
+60% +$335K 0.09% 71
2020
Q4
$505K Buy
+2,061
New +$532K 0.06% 83

Other funds holding BIIB

Harvest Volatility Management's BIIB Position: Q3 2023 in Review

Harvest Volatility Management sold out of Biogen (BIIB) in Q3 2023, closing a stake of 4,461 shares — an estimated $1.27M sold.

Harvest Volatility Management first reported a position in BIIB in Q4 2020 and held it in 11 quarters. The position peaked at $2.03M in Q3 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • Harvest Volatility Management reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • Harvest Volatility Management sold 4,461 Biogen shares in Q3 2023, an estimated $1.27M.
  • Harvest Volatility Management first reported a position in Biogen in Q4 2020 and held it in 11 quarters.
  • Harvest Volatility Management's Biogen position peaked at $2.03M in Q3 2022.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Harvest Volatility Management's 13F filing for Q3 2023, filed 7 Nov 2023.